Episode 19 is the first of two episodes that will discuss a topic near and dear to us here at NETRF: NET research. Advancing NET research is the core of our mission, and it’s a crucial need, because NETs are extremely complicated cancers and there is still a lot the medical community needs to learn about them. 

How do scientists do research, from beginning to end? And what are some of the challenges that specifically face NET researchers as they work through that process?  Learn why basic research in the laboratory is crucial to discovering new treatments. Clinical trials are just the last stage of this process, and they cannot happen without years of careful pre-clinical work, which is often underappreciated and underfunded.

After you’ve listened to the episode, test your NET Knowledge by taking the LACNETS quiz here. 

John Kanki, PhD
Director of Research
NETRF

Dawn Quelle, PhD 
Professor of Pharmacology and Neurology
Holden Comprehensive Cancer Center University of Iowa, College of Medicine
Co-Chair of NETRF Board of Scientific Advisors

Ramesh Shivdasani, MD, PhD 
Oncologist,
Dana-Farber Cancer Institute
Professor,
Harvard Medical School
NETRF Board of Scientific Advisors

Chrissie Thirlwell, MD, PhD
Mireille Gillings Professor of Cancer Genomics
University of Exeter 

Co-Chair of NETRF Board of Scientific Advisors

Request a Mailed Copy of our Neuroendocrine Cancer Guide

Information and Resources for the Newly Diagnosed

NETRF YouTube Channel

NETWise Episode 31: 2023 Year in Review

NETRF 2023 Research Symposium: Personalized Medicine

NETRF 2023 Research Symposium: Improving Radiotheranostics

NETRF 2023 Research Symposium: NET Pathways & Targets

NETRF 2023 Research Symposium: Tumor Evolution & Microenvironment

NETRF 2024 Know Your NETs Virtual Conference: Combining & Sequencing Novel

NETRF 2024 Providence Conference: Basic and Translational Research

NETRF 2024 Providence Conference: NET Clinical Trials

NETRF 2024 Know Your NETs Virtual Conference: Welcome & Discovery in NETs w/ Basic

Celebrating Milestones in Neuroendocrine Tumor Research (2023)

NETRF Awards Eleven Research Grants to Study Neuroendocrine Cancer

NETRF Research Highlights 2023: Drug-tolerant persister cells in relapsed high-grade neuroendocrine carcinoma, by Carl Gay, MD, PhD

NETRF Research Highlights 2023: NET-SMART therapy, a targeted prodrug strategy, by Justin Annes, MD, PhD

NETRF Research Highlights 2023: Imaging and endo radiotherapy of NETs by endocytic modulation of somatostatin receptors, by Patricia Pereira, PhD

NETRF Research Highlights 2023: Targeting serotonin metabolism in small bowel NETs, by Po Hien Ear, PhD

NETRF Research Highlights 2023: Novel PDXovo models for neuroendocrine neoplasms, by Iacovos Michael, PhD

Advancing Neuroendocrine Tumor Research Through a New Clinically Relevant Mouse Model

The post Episode 19: NET Research—Part One appeared first on NETRF.